{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:04:20Z","timestamp":1789070660667,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ajo.2018.03.024","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T14:23:33Z","timestamp":1521555813000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1340-6758","authenticated-orcid":false,"given":"Jia","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Kheirkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dohlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujwala","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ajo.2018.03.024_bib1","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ophtha.2009.04.054","article-title":"Ocular findings after allogeneic hematopoietic stem cell transplantation","volume":"116","author":"Tabbara","year":"2009","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2018.03.024_bib2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/ICO.0b013e3181ca321c","article-title":"Ocular graft-versus-host disease after allogeneic stem cell transplantation","volume":"29","author":"Westeneng","year":"2010","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2018.03.024_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.survophthal.2012.08.004","article-title":"Ocular graft-versus-host disease: a review","volume":"58","author":"Shikari","year":"2013","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2018.03.024_bib4","first-page":"351","article-title":"Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations","volume":"8","author":"Nassiri","year":"2013","journal-title":"J Ophthalmic Vis Res"},{"issue":"5","key":"10.1016\/j.ajo.2018.03.024_bib5","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/ACI.0b013e328357b4b9","article-title":"Ocular graft-versus-host disease","volume":"12","author":"Hessen","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.ajo.2018.03.024_bib6","first-page":"1209","article-title":"Ocular manifestations of graft-versus-host disease: 10 years\u2019 experience","volume":"9","author":"Lin","year":"2015","journal-title":"Clin Ophthalmol"},{"issue":"7 Suppl","key":"10.1016\/j.ajo.2018.03.024_bib7","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/00003226-200310001-00004","article-title":"Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation","volume":"22","author":"Ogawa","year":"2003","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2018.03.024_bib8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/bmt.2009.312","article-title":"Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye","volume":"45","author":"Wang","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.ajo.2018.03.024_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II Management and Therapy Report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"issue":"4-5","key":"10.1016\/j.ajo.2018.03.024_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08820538.2011.588663","article-title":"Keratoconjunctivitis sicca manifestations in ocular graft versus host disease: pathogenesis, presentation, prevention, and treatment","volume":"26","author":"Townley","year":"2011","journal-title":"Semin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2018.03.024_bib11","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00417-013-2301-z","article-title":"Graft versus host disease: clinical evaluation, diagnosis and management","volume":"251","author":"Espana","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2018.03.024_bib12","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ophtha.2014.11.006","article-title":"Effects of corneal nerve density on the response to treatment in dry eye disease","volume":"122","author":"Kheirkhah","year":"2015","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2018.03.024_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry eye disease: an immune-mediated ocular surface disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2018.03.024_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.preteyeres.2012.02.003","article-title":"Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease","volume":"31","author":"Barabino","year":"2012","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2018.03.024_bib15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archopht.1983.01040010580010","article-title":"The eye in bone marrow transplantation. I. Clinical study","volume":"101","author":"Hirst","year":"1983","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2018.03.024_bib16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archopht.1989.01070020413046","article-title":"The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease","volume":"107","author":"Jabs","year":"1989","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2018.03.024_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbmt.2005.11.155","article-title":"Ocular graft vs. host disease experience from MD Anderson Cancer Center: newly described clinical spectrum and new approach to the management of stage III and IV ocular GVHD","volume":"12","author":"Kim","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.ajo.2018.03.024_bib18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.bmt.1704453","article-title":"Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease","volume":"33","author":"Robinson","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.ajo.2018.03.024_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","article-title":"Efficacy and safety of topical 0.05% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis","volume":"13","author":"Wan","year":"2015","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajo.2018.03.024_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bmt.1705900","article-title":"Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease","volume":"41","author":"Wang","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.ajo.2018.03.024_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.ico.0000208818.47861.1d","article-title":"Ophthalmic cyclosporine use in ocular GVHD","volume":"25","author":"Lelli","year":"2006","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.ajo.2018.03.024_bib22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/ICO.0b013e3181a16472","article-title":"High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen","volume":"28","author":"Dastjerdi","year":"2009","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.ajo.2018.03.024_bib23","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/ICO.0b013e3181e456f0","article-title":"Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%","volume":"29","author":"Malta","year":"2010","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ajo.2018.03.024_bib24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/096368970901805-620","article-title":"Comparative study of the cellular pharmacodynamics of calcineurin inhibitors between patients with chronic renal failure awaiting renal transplantation and cirrhosis patients awaiting liver transplantation","volume":"18","author":"Kihara","year":"2009","journal-title":"Cell Transplant"},{"issue":"7","key":"10.1016\/j.ajo.2018.03.024_bib25","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ophtha.2016.02.044","article-title":"A clinical trial comparing the safety and efficacy of topical tacrolimus versus methylprednisolone in ocular graft-versus-host disease","volume":"123","author":"Abud","year":"2016","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2018.03.024_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jtos.2016.01.001","article-title":"Lifitegrast, a novel integrin antagonist for treatment of dry eye disease","volume":"14","author":"Perez","year":"2016","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2018.03.024_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12177-008-9006-2","article-title":"Quantitative assessment of tear production: A review of methods and utility in dry eye drug discovery","volume":"1","author":"Senchyna","year":"2008","journal-title":"J Ocul Biol Dis Infor"},{"issue":"6","key":"10.1016\/j.ajo.2018.03.024_bib28","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00417-014-2618-2","article-title":"Image-guided evaluation and monitoring of treatment response in patients with dry eye disease","volume":"252","author":"Qazi","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2018.03.024_bib29","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1167\/iovs.16-20013","article-title":"In\u00a0vivo confocal microscopy in dry eye disease associated with chronic graft-versus-host disease","volume":"57","author":"Kheirkhah","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11S","key":"10.1016\/j.ajo.2018.03.024_bib30","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.ophtha.2017.07.022","article-title":"Update in current diagnostics and therapeutics of dry eye disease","volume":"124","author":"Thulasi","year":"2017","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2018.03.024_bib31","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtos.2017.03.006","article-title":"TFOS DEWS II tear film report","volume":"15","author":"Willcox","year":"2017","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2018.03.024_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","article-title":"Locally administered ocular corticosteroids: benefits and risks","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.ajo.2018.03.024_bib33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00417-016-3312-3","article-title":"Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease","volume":"254","author":"Saboo","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418301259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418301259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:36:02Z","timestamp":1757597762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939418301259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":33,"alternative-id":["S0002939418301259"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2018.03.024","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2018.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}